Compare Howmet Aerospace Inc (HWM) vs Merck & Co., Inc. (MRK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Howmet Aerospace Inc vs Merck & Co., Inc. — how do they compare? Howmet Aerospace Inc trades at $280.9 (market cap $111.63B), while Merck & Co., Inc. trades at $128.33 (market cap $311.84B). The key difference: Merck & Co., Inc. is far larger — about 2.8× Howmet Aerospace Inc's market cap, and Merck & Co., Inc. pays the higher dividend (2.69%). Which is the better fit depends on your goals.
| HWM | MRK | |
|---|---|---|
Market Cap | $111.63B | $311.84B |
Sector | Industrials | Health |
52-Week High | $283.23 | $129.52 |
52-Week Low | $171.00 | $77.60 |
Enterprise Value | $113.88B | $355.26B |
Dividend Yield | 0.17% | 2.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Howmet Aerospace (HWM) trades at $271.98, down 0.17% on the day, with technical indicators showing a neutral trend. The company demonstrates strong fundamentals with consistent earnings beats, including Q1 2026 EPS of $1.22 beating expectations of $1.11, and robust profitability with a 20.22% net income margin. Recent news highlights strength in commercial aerospace demand driving growth prospects.
The outlook remains positive with 84% analyst buy ratings and a $317.63 consensus price target implying 17% upside. Key risks include premium valuation multiples and exposure to aerospace cycle volatility. Continued execution on commercial aerospace growth and defense contracts supports the bullish case, though investors should monitor Q2 2026 earnings due August 6 for confirmation.
Merck (MRK) trades at $127.52, up 2.5% today, with a bullish technical signal and strong analyst consensus. The stock recently beat earnings estimates in Q1 2026 and announced a $6.7 billion acquisition of Terns Pharmaceuticals to bolster its oncology pipeline. Revenue grew to $65.01 billion in 2025, with a net income margin of 28.07%, though 2026 forecasts show a decline in profitability. Cash flow remains positive, but debt levels have increased.
The outlook is positive due to strategic acquisitions and earnings beats, but risks include rising debt, competitive pressures, and a projected profit margin drop in 2026. The consensus price target of $137.30 suggests modest upside, supported by institutional buying and a bullish technical trend.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Howmet Aerospace Inc
Howmet Aerospace provides advanced engineered solutions for the aerospace and transportation industries. It specializes in jet engine components, aerospace fastening systems, and forged aluminum wheels.
Read more on HWM →About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →
